Zheng Liu
About
Zheng Liu has authored 173 papers that have received a total of 3.8k indexed citations.
This includes 67 papers in Molecular Biology, 32 papers in Rheumatology and 25 papers in Epidemiology. The topics of these papers are IgG4-Related and Inflammatory Diseases (17 papers), Neuroendocrine Tumor Research Advances (13 papers) and Epigenetics and DNA Methylation (11 papers). Zheng Liu is often cited by papers focused on IgG4-Related and Inflammatory Diseases (17 papers), Neuroendocrine Tumor Research Advances (13 papers) and Epigenetics and DNA Methylation (11 papers) and collaborates with scholars based in China, United States and Hong Kong. Zheng Liu's co-authors include Hui Lu, Yunyun Fei, Linyi Peng and Panpan Zhang and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nucleic Acids Research.
In The Last Decade
Fields of papers published by Zheng Liu
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries citing papers authored by Zheng Liu
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Dabang Jiang Breakdown of academic impact, for papers by Raimondo Germani Breakdown of academic impact, for papers by Takashi Yamamoto Breakdown of academic impact, for papers by Kotaro Oka Breakdown of academic impact, for papers by Song Chen Breakdown of academic impact, for papers by Norbert H. Menzler Breakdown of academic impact, for papers by A. Asensio Ramos Breakdown of academic impact, for papers by P. J. Mouginis‐Mark